Inogen

Inogen Free Cash Flow

The Free Cash Flow (FCF) of Inogen (INGN) as of Nov 20, 2026 is -21.60 M USD. In the previous year, Free Cash Flow (FCF) was -11.18 M USD — a change of 93.21% (lower).

Free Cash Flow

-21.60 MUSD

YoY

93.21%

Last updated:

Free Cash Flow (FCF) of Inogen is 2025 -21.60 M USD. Free Cash Flow (FCF) of Inogen was 2024 -11.18 M USD. It decreases by 93.21% lower compared to the previous year.

The Inogen Free Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Free Cash Flow
Date
Free Cash Flow
Jan 1, 2018
47.00 M USD
Jan 1, 2019
34.08 M USD
Jan 1, 2020
19.67 M USD
Jan 1, 2021
-302,000.00 USD
Jan 1, 2022
-58.75 M USD
Jan 1, 2023
-29.75 M USD
Jan 1, 2024
-11.18 M USD
Jan 1, 2025
-21.60 M USD
The Inogen Free Cash Flow history
YEARFree Cash FlowYoY
-21.60 MUSD+93.21%
-11.18 MUSD-62.42%
-29.75 MUSD-49.36%
-58.75 MUSD+19,354.97%
-302,000.00USD-101.54%
19.67 MUSD-42.28%
34.08 MUSD-27.50%
47.00 MUSD-6.49%
50.27 MUSD+118.38%
23.02 MUSD-10.34%
25.67 MUSD-4,854.07%
-540,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inogen stock

Free Cash Flow (FCF) of Inogen is -21.60 M USD in 2025.

Free Cash Flow (FCF) of Inogen changed from -11.18 M USD to -21.60 M USD, representing a 93.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow (FCF) Inogen since 2006 – with annual values, charts, and detailed analysis.

Free Cash Flow is the cash available after capital expenditures. It represents the cash a company can use for dividends, debt reduction, or reinvestment.

FCF = Operating Cash Flow - Capital Expenditures

Free Cash Flow (FCF)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Free Cash Flow (FCF)'s Inogen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Inogen

All Key Metrics — Inogen